Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 17Terminated 6Recruiting 5Unknown 3Withdrawn 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5CNS 5Other neoplasm 2Gynecologic 2Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Glioblastoma 3Neurofibromatosis 1 1Neurofibroma 1Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 79Magnetic Resonance Spectroscopy 68Specimen Handling 45Radiotherapy 42Bevacizumab 29Radiosurgery 27Cyclophosphamide 27Radiation 20pembrolizumab 19Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 15Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11dinutuximab 9Surgical Procedures, Operative 9trametinib 8abemaciclib 8Ipilimumab 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7Magnetic Resonance Imaging 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Aminolevulinic Acid × CNS × Clear all
NCT07225621 2026-06-05

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

Alpheus Medical, Inc.

Phase 2 Recruiting
103 enrolled
CNS

Glioblastoma

NCT07076472 2026-02-23

Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
8 enrolled
CNS

Glioblastoma

NCT02691923 2025-08-03

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
30 enrolled
CNS

Brain Neoplasms, Glioma

NCT02728388 2025-05-08

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Medical College of Wisconsin

Phase 2 Recruiting
30 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

NCT05590689 2024-12-16

ALA-RDTinGBM

Universität Münster

Phase 1/2 Recruiting
34 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡